Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer.
about
Clinical applications for diffusion magnetic resonance imaging in radiotherapyDemonstration of nonlinearity bias in the measurement of the apparent diffusion coefficient in multicenter trials.Identifying MRI markers to evaluate early treatment related changes post laser ablation for cancer pain management.Quantitative evaluation of multi-parametric MR imaging marker changes post-laser interstitial ablation therapy (LITT) for epilepsy.A Domain Constrained Deformable (DoCD) Model for Co-registration of Pre- and Post-Radiated Prostate MRI.Identifying MRI markers associated with early response following laser ablation for neurological disorders: preliminary findings.Association of computerized texture features on MRI with early treatment response following laser ablation for neuropathic cancer pain: preliminary findings.Quantifying Post- Laser Ablation Prostate Therapy Changes on MRI via a Domain-Specific Biomechanical Model: Preliminary Findings.Correction of Gradient Nonlinearity Bias in Quantitative Diffusion Parameters of Renal Tissue with Intra Voxel Incoherent MotionProstate cancer magnetic resonance imaging (MRI): multidisciplinary standpoint.The role of metabolic imaging in radiation therapy of prostate cancer.QIN DAWG Validation of Gradient Nonlinearity Bias Correction Workflow for Quantitative Diffusion-Weighted Imaging in Multicenter TrialsMulti-modality organ-based approach to expected imaging findings, complications and recurrent tumour in the genitourinary tract after radiotherapy.Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer clinical trials: potential roles and possible pitfalls.Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems.Prostate cancer detection using quantitative T2 and T2 -weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillance.Performance of a fast and high-resolution multi-echo spin-echo sequence for prostate T2 mapping across multiple systems.Diffusion-weighted MRI treatment monitoring of primary hypofractionated proton and carbon ion prostate cancer irradiation using raster scan technique.Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancer.
P2860
Q27005757-D8841491-D05D-489D-952A-415B96771589Q30944029-01EE4EF5-843A-475E-BCE0-722AAA710A84Q33954963-34E3124A-BF85-4596-A367-290BEADC5D21Q33959196-06C6704A-1262-401F-8E77-DA61A03AECFEQ34245534-E17F1994-1B39-4DD4-8871-7ECF47862616Q35517507-940E23BE-6278-4DEA-8171-2A17ADF0B97FQ35921840-84826488-C937-4E78-B332-9202137ECBD6Q35992388-3CC4B290-60BB-4C82-AF96-01F871C8E350Q36493911-A764D42D-57E1-417D-BE66-F622F772A005Q36795496-0BF1E020-A676-4E92-9FCB-2FEBE3DB1AC5Q37395733-57560A76-29F8-4D73-98CC-413D7CF870DFQ37590329-F7D70237-1A57-4B16-9177-859B2A58A013Q37628932-62DD8A8B-E6FD-47FB-94F6-1BC4FB795064Q37721529-193C4AED-E2EC-4B63-9463-D0C2C593841FQ38786175-1EECFF2E-3D09-4BD8-B71A-1652A31C16ABQ47601675-4BA50CAD-5489-4971-9470-7C8384374B7EQ47964968-69D24B20-16A1-4946-BD5B-53B92A880A7DQ50916519-DD801129-DD60-4373-88BA-D3E7A4C44E49Q51041919-4201D764-A2A9-4162-BA41-6330DF3A83B4
P2860
Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Changes in apparent diffusion ...... iotherapy for prostate cancer.
@en
Changes in apparent diffusion ...... iotherapy for prostate cancer.
@nl
type
label
Changes in apparent diffusion ...... iotherapy for prostate cancer.
@en
Changes in apparent diffusion ...... iotherapy for prostate cancer.
@nl
prefLabel
Changes in apparent diffusion ...... iotherapy for prostate cancer.
@en
Changes in apparent diffusion ...... iotherapy for prostate cancer.
@nl
P2093
P2860
P50
P356
P1476
Changes in apparent diffusion ...... diotherapy for prostate cancer
@en
P2093
Andrew Bayley
Anna Simeonov
Charles Catton
Cynthia Ménard
Masoom A Haider
Warren D Foltz
P2860
P304
P356
10.1002/JMRI.23885
P577
2012-10-23T00:00:00Z